You are here

P&T April 2011

Features

Commentary
FDA Plans New National Standards, Pharmacies Tread With Trepidation
Results From a Large Inpatient Database

In a study to evaluate the economic impact of the alvimopan after bowel surgery, the authors found that patients receiving alvimopan capsules had faster recoveries, lower hospital costs, and shorter stays than matched controls.


Current and Potential Therapies
Meeting Highlights
Three Leading Candidates